U.S. flag

An official website of the United States government

Filters

See more specimen types...

Other countries

Results: 1 to 20 of 36

Tests names and labsConditionsGenes, analytes, and microbesMethods

Polypharmacy Comprehensive Panel

Invitae
United States
3324
  • D Deletion/duplication analysis
  • T Targeted variant analysis

CYP2D6 Gene Sequencing Panel (2 Day STAT TAT)

Machaon Diagnostics
United States
11
  • D Deletion/duplication analysis
  • E Sequence analysis of select exons

Codeine sensitivity, 608902, Autosomal recessive (MLPA)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • D Deletion/duplication analysis

Codeine sensitivity, 608902, Autosomal recessive (CYP2D6 gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

CYP2D6 (CYP2D6 gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Debrisoquine sensitivity, 608902, Autosomal recessive (CYP2D6 gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Debrisoquine sensitivity, 608902, Autosomal recessive (MLPA)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • D Deletion/duplication analysis

Pharmacogenomics Test Panel

IU Genetic Testing Laboratories Indiana University School of Medicine
United States
813
  • T Targeted variant analysis

CYP2D6 Genotyping

IU Genetic Testing Laboratories Indiana University School of Medicine
United States
11
  • T Targeted variant analysis

CYP450 Panel - TCA/SSRI

Molecular Diagnostics Children's Hospital of Wisconsin
United States
22
  • D Deletion/duplication analysis
  • T Targeted variant analysis

Pharmacogenetics Panel

Mako Medical Laboratories
United States
66
  • D Deletion/duplication analysis
  • T Targeted variant analysis

CYP450 drug metabolizing enzyme mutation panel

Molecular Diagnostics Children's Hospital of Wisconsin
United States
33
  • T Targeted variant analysis

CYP2D6 drug metabolizing enzyme gene mutation

Molecular Diagnostics Children's Hospital of Wisconsin
United States
11
  • D Deletion/duplication analysis
  • T Targeted variant analysis

Drug Metabolizing Enzymes and Transporters

Developmental and Neurogenetics Laboratory Medical College of Wisconsin
United States
33
  • T Targeted variant analysis

Basic Pharmacogenetics

Genologica Medica
Spain
46
  • C Sequence analysis of the entire coding region

Dyslipidemia and early atherosclerosis panel. 84-gene NGS panel.

Genologica Medica
Spain
13384
  • C Sequence analysis of the entire coding region

Tamoxifen toxicity. Study of polymorphisms in the CYP2D6 gene

Genologica Medica
Spain
11
  • C Sequence analysis of the entire coding region

Cytochrome P450 Genotyping Panel, with GeneDose Access

ARUP Laboratories, Molecular Genetics and Genomics ARUP Laboratories
United States
97
  • T Targeted variant analysis

CYP2D6 Mutation Analysis

Duzen Laboratories Duzen BBAGUAS
Turkey
11
  • T Targeted variant analysis

CYP2D6 Genotype Analysis

Cincinnati Children's Hospital Medical Center Genetics and Genomics Diagnostic Laboratory Cincinnati Children's Hospital Medical Center
United States
11
  • T Targeted variant analysis

Results: 1 to 20 of 36

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.